TrialEuropean journal of neurology2014

Pooled analysis of the safety and tolerability of onabotulinumtoxinA in the treatment of chronic migraine.

H-C Diener et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.